Skip to main content

Enter a phrase above to search within the site.

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Agenda - Advisory Council Meeting for May 15, 2018
DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM AGENDA 148th Meeting of the NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM Tuesday, May 15, 2018 Fishers Lane, Terrace Conference Rooms, Rockville MD 20852 9:45 AM - 3:00 PM: OPEN TO THE PUBLIC 9:45 CALL TO ORDER AND INTRODUCTIONS Dr. George Koob...

Event

Pharmacotherapy Webinar featuring Dr. Sandra Springer, Yale AIDS Program
Friday, November 20, 2020, 12:00 pm EST to Friday, November 20, 2020, 10:00 pm EST
NEW LOCATION: Zoom Platform Webinar Title: Pharmacotherapy of Addiction Integrated with HIV Treatment Upon Reentry into the Community from Prison Improves Outcomes Speaker: Sandra Springer, MD, Associate Professor of Medicine, Yale School of Medicine, Section of Infectious Disease, Yale AIDS Program, VA Connecticut Healthcare System Access the Zoom link here: https://bit.ly/ReturningCitizens2 Meeting number/Access Code: 126 600 0267 Password: FridayNov20 Join...
165th Meeting of the NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM Thursday, February 8, 2024
DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM AGENDA 165th Meeting of the NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM Thursday, February 8th, 2024 Videoconference https://videocast.nih.gov/watch=53825 12:00 PM to 4:20 PM EDT: OPEN TO THE PUBLIC (NIH VIDEOCAST) 12:00 PM CALL TO ORDER AND ROLL CALL Dr. George Koob 12:15...
LPS - Section on Neuroendocrinology (NE)

George Kunos MD. , PhD. Chief National Institute on Alcohol Abuse and Alcoholism National Institutes of Health 5625 Fishers Lane, Room 2S-24:MSC 9413 Bethesda MD 20892-9413 telephone: +1 301.443.2069 fax: +1 301.480.0257 e-mail: gkunos@mail.nih.gov Mission Statement The Biology and Functions of the Endocannabinoid System Endocannabinoids are lipid-like mediators discovered in the 1 990s that bind to cannabinoid receptors to trigger...

Event

Webinar: Women, Pregnancy and Addiction: Understanding and Addressing Stigma Amongst Healthcare Providers and the General Public
Friday, November 22, 2019, 11:00 am EST
The: Interagency Work Group on Drinking and Drug Use in Women and Girls will sponsor the following webinar: Women, Pregnancy and Addiction: Understanding and Addressing Stigma Amongst Healthcare Providers and the General Public Friday, November 22, 2019 11:00 am – 12:00 pm EST Join WebEx Meeting: https://nih.webex.com/nih Call-in toll number (US/Canada) 1-650-479-3208 Meeting Number (access code) 628-471-581 Meeting Password: NIAAA...
Study Points to NK1R Blocker as Possible Alcoholism Treatment

Neurokinin-1 receptors (NK1R) are highly expressed in brain areas involved in stress responses and drug reward. In recent years, mounting research evidence has suggested that they may help regulate important aspects of alcohol use. In a new study, researchers at the NIAAA report that a compound that blocks NK1R suppresses alcohol drinking in mice. NIAAA Clinical Director Markus Heilig, M.D...

The "Drunkometer" to Digital Apps: How Technology Changes the Way We Drink

The NIH Institute on Alcohol and Alcohol Abuse (NIAAA) has issued a national challenge to design a wearable or discreet device to measure blood alcohol levels. Tonight’s discussion examines the history and current research on alcohol consumption and the promise of new technology. First used by the criminal justice system to enforce drunk driving laws, alcohol monitoring technology now has...

Andrea M. Harris, SAMHSA
Andrea M. Harris, M.S. Lead Public Health Advisor Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration (SAMHSA) 5600 Fishers Lane, 13E77-D Rockville, MD 20857 Phone: (240) 276-2441 Fax: (240)276-2560 Email: andrea.harris@samhsa.hhs.gov Biographical Summary Andrea M. Harris has worked in the field of substance abuse and mental health treatment and prevention for over 35 years. Ms. Harris...

Announcement

In Memoriam - Enoch Gordis, MD
NIAAA and the scientific community mourn the death on April 5th of Enoch Gordis, M.D., who served as the NIAAA director from 1986 to 2001. Dr. Gordis emphasized science as a way of understanding alcohol use disorder (AUD). He earned his undergraduate and medical degrees at Columbia University in New York City. Trained in internal medicine, Dr. Gordis conducted research...
Quetiapine Study

Data Access Policy, Application and Agreement NIAAA Protocol NCIG 001: A Multisite Double-Blind, Placebo-Controlled Trial of Quetiapine Fumarate XR in Very Heavy-Drinking Alcohol-Dependent Patients Description  This double-blind, randomized placebo-controlled trial evaluated the efficacy and safety of quetiapine, for the treatment of alcohol use disorder (AUD).   Study Details  Sponsor: The National Institute on Alcohol Abuse and Alcoholism’s Clinical Investigations Group (NCIG) ...

NIAAA T32 and T35 Supplemental Information
Supplemental Information for National Institute on Alcohol Abuse and Alcoholism (NIAAA) Institutional National Research Service Awards (T32 and T35) I. INTRODUCTION This policy statement of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) supplements the general guidelines of the National Institutes of Health (NIH) as described in the program announcements “Ruth L. Kirschstein National Research Service Award (NRSA) Institutional...
¿Qué es una bebida estándar?
Muchas personas se sorprenden al saber lo que cuenta como una bebida. La cantidad de líquido en su vaso, lata o botella no necesariamente coincide con la cantidad de alcohol que hay realmente en su bebida. Los diferentes tipos de cerveza, vino o licor de malta pueden tener cantidades muy diferentes de contenido de alcohol. Por ejemplo, muchas cervezas ligeras...
NIAAA Statement on Research Priorities and Procedures

National Institute on Alcohol Abuse and Alcoholism, NIH Research Priorities and Procedures The National Institute on Alcohol Abuse and Alcoholism (NIAAA) is one of the 27 institutes and centers that comprise the National Institutes of Health (NIH). NIAAA supports and conducts research on the impact of alcohol use on human health and well-being. It is the largest funder of alcohol...

NIAAA DTRR NOSI Concept Clearance
Raye Litten, Ph.D.; Brett Hagman, Ph.D., Laura Kwako, Ph.D.; Deidra Roach, M.D., and Mariela Shirley, Ph.D. Purpose The purpose of this Notice of Special Interest (NOSI) is to advance research on various topics that fall within NIAAA’s Division of Treatment and Recovery Research (DTRR). DTRR’s research interests are wide-ranging but typically encompass broad categories such as health services, behavioral therapies...

Event

Achieving Equity in Women’s Addiction Prevention and Treatment: Accent on Promising Programs
Friday, June 16, 2023, 11:00 am EDT to Friday, June 16, 2023, 12:00 pm EDT
You are cordially invited to join the Interagency Work Group on Drinking and Drug Use in Women and Girls for our next webinar coming up this coming Friday, June 16, 2023, 11:00 am – 12:00 pm EST . Details are as follows: Title: Achieving Equity in Women’s Addiction Prevention and Treatment: Accent on Promising Programs Speakers: Chyrell D. Bellamy, PhD...
Laboratory of Neuroimaging
Laboratory of Neuroimaging (LNI) National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institutes of Health 10 Center Drive, Room B2L124: MSC 1013 Bethesda, MD 20892-1013 Chief of Laboratory Nora D. Volkow, MD Senior Investigator , NIAAA Director , National Institute on Drug Abuse (NIDA) Phone: 1 (301) 402-0868 E-mail: nvolkow@nida.nih.gov Dr. Volkow became Director of the National Institute on...
Fetal Alcohol Spectrum Disorders May Increase the Risk of Type 2 Diabetes and Other Metabolic Issues

Adults with fetal alcohol spectrum disorders (FASD) may have an increased risk of type 2 diabetes, and other metabolic abnormalities such as low HDL cholesterol and elevated levels of triglycerides compared to people without FASD, according to a new study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health. The research...

Fetal Alcohol Spectrum Disorders May Increase the Risk of Type 2 Diabetes and Other Metabolic Issues
Adults with fetal alcohol spectrum disorders (FASD) may have an increased risk of type 2 diabetes, and other metabolic abnormalities such as low HDL cholesterol and elevated levels of triglycerides compared to people without FASD, according to a new study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health. The research...
Looking for U.S. government information and services?
Visit USA.gov